Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

9.015 -0.705 (-7.25%)
Streaming Delayed Price Updated: 11:07 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 Next >
Peering Into Elanco Animal Health's Recent Short Interest
Via Benzinga
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
1 Small-Cap Stock to Target This Week and 2 to Turn Down
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have... 
Via StockStory
Earnings Scheduled For February 25, 2025
Via Benzinga
Beyond The Numbers: 5 Analysts Discuss Elanco Animal Health Stock
Via Benzinga
(ELAN) - Analyzing Elanco Animal Health's Short Interest
Via Benzinga
3 Stocks Under $50 in Hot Water
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
Tesla To $370? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff
Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed forecasts. 2025 guidance lags consensus as currency headwinds pose a $110 million challenge. 
Via Benzinga
Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript
ELAN earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Elanco (NYSE:ELAN) Surprises With Q4 Sales
Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.02 billion. On the other hand, the company’s... 
Via StockStory
Top 3 Health Care Stocks That Could Blast Off In December
Via Benzinga
Analyst Ratings For Elanco Animal Health
Via Benzinga
Elanco (ELAN) Q4 Earnings Report Preview: What To Look For
Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for. 
Via StockStory
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in. 
Via Benzinga
Topics Stocks
Exposures US Equities
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Evaluating Elanco Animal Health: Insights From 4 Financial Analysts
Via Benzinga
Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews
Via Benzinga
A Closer Look at 4 Analyst Recommendations For Elanco Animal Health
Via Benzinga
Elanco Animal Health (ELAN) Q3 2024 Earnings Call Transcript
ELAN earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Elanco Animal Q3 Earnings: Profit Beat, New Products And Stabilized Business To Drive 2025 Sales
Elanco Animal Health reports Q3 revenue of $1.03 billion, with a 4% decline and adjusted EPS of $0.13, beating estimates. Guidance tightened for 2024 sales and EPS. 
Via Benzinga
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to... 
Via Benzinga
Exposures Product Safety
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Elanco Animal Health (ELAN) Q2 2024 Earnings Call Transcript
ELAN earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside. 
Via InvestorPlace
Merk Animal Health Completes Acquisition of Elanco Animal Health Assets
Merck Animal Health announced the purchase of Elanco Animal Health's aquaculture business.Merck & Company (NYSE:MRK) completed the acquisition of the aquaculture bus 
Via Benzinga
Citigroup, Elanco Animal Health And A Tech Stock: CNBC's 'Final Trades'
Analysts expect Citigroup to report good earnings on Friday. Stephanie Link chose Elanco for its new products. Corning increased its sales guidance. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.